MILANO VINCENT
Insider CIK 1187159 · VNDA Director · ACRS Director · ONCE Director · IDRA President and CEO, Director · BCRX Director · VPHM President and CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2026-08-31 | 2026-09-02 | 1,159 | $9.70 | $11.2K | 109,642 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2026-08-31 | 2026-09-02 | 1,159 | $9.70 | $11.2K | 109,642 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2026-06-11 | 2026-06-15 | 33,540 | — | $0 | 33,540 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2026-06-11 | 2026-06-15 | 15,294 | — | $0 | 108,483 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2026-06-05 | 2026-06-08 | 11,580 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2026-06-05 | 2026-06-08 | 11,580 | — | $0 | 28,896 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2026-06-04 | 2026-06-08 | 10,987 | — | $0 | 10,987 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2026-06-04 | 2026-06-08 | 42,350 | — | $0 | 42,350 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2026-05-29 | 2026-06-02 | 1,122 | $8.91 | $10.0K | 93,189 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2026-02-27 | 2026-03-03 | 848 | $8.75 | $7.4K | 92,067 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2025-11-28 | 2025-12-02 | 783 | $7.18 | $5.6K | 91,219 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2025-08-29 | 2025-09-03 | 676 | $8.31 | $5.6K | 90,436 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2025-06-12 | 2025-06-16 | 27,181 | — | $0 | 27,181 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2025-06-12 | 2025-06-16 | 12,500 | — | $0 | 89,760 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2025-06-06 | 2025-06-09 | 4,793 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2025-06-06 | 2025-06-09 | 4,793 | — | $0 | 17,316 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2025-06-05 | 2025-06-09 | 42,350 | — | $0 | 42,350 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2025-06-05 | 2025-06-09 | 11,580 | — | $0 | 11,580 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2025-05-30 | 2025-06-03 | 523 | $10.75 | $5.6K | 77,260 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2025-02-28 | 2025-03-04 | 653 | $8.61 | $5.6K | 76,737 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2024-11-29 | 2024-12-02 | 750 | $7.50 | $5.6K | 76,084 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2024-08-30 | 2024-09-03 | 647 | $8.69 | $5.6K | 75,334 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2024-06-12 | 2024-06-14 | 49,933 | — | $0 | 49,933 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2024-06-12 | 2024-06-14 | 6,820 | — | $0 | 74,687 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2024-06-06 | 2024-06-10 | 15,750 | — | $0 | 15,750 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2024-06-06 | 2024-06-10 | 4,793 | — | $0 | 4,793 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2024-06-01 | 2024-06-04 | 4,660 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2024-06-01 | 2024-06-04 | 4,660 | — | $0 | 12,523 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2024-05-31 | 2024-06-03 | 870 | $6.46 | $5.6K | 67,867 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | P Buy | 2024-05-20 | 2024-05-22 | 15,000 | $6.25 | $93.8K | 66,997 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2024-02-29 | 2024-03-04 | 999 | $5.63 | $5.6K | 51,997 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2023-11-30 | 2023-12-01 | 956 | $5.88 | $5.6K | 50,998 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2023-08-31 | 2023-09-05 | 791 | $7.11 | $5.6K | 50,042 | SEC↗ |
| ACGN Aceragen, Inc. | S Sale | 2023-08-10 | 2023-08-11 | 3,283 | $0.53 | $1.7K | 8,987 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2023-06-13 | 2023-06-15 | 39,072 | — | $0 | 39,072 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2023-06-13 | 2023-06-15 | 16,745 | — | $0 | 49,251 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2023-06-02 | 2023-06-05 | 4,507 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2023-06-02 | 2023-06-05 | 4,507 | — | $0 | 7,863 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2023-06-01 | 2023-06-05 | 15,750 | — | $0 | 15,750 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2023-06-01 | 2023-06-05 | 4,660 | — | $0 | 4,660 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2023-05-31 | 2023-06-02 | 680 | $8.27 | $5.6K | 32,506 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2023-02-28 | 2023-03-02 | 635 | $8.85 | $5.6K | 31,826 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2022-11-30 | 2022-12-02 | 421 | $13.36 | $5.6K | 31,191 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2022-08-31 | 2022-09-02 | 404 | $13.90 | $5.6K | 30,770 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2022-07-06 | 2022-07-07 | 124,000 | — | $0 | 124,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2022-06-07 | 2022-06-09 | 30,022 | — | $0 | 30,022 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2022-06-07 | 2022-06-09 | 12,866 | — | $0 | 30,366 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2022-06-03 | 2022-06-06 | 3,356 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2022-06-03 | 2022-06-06 | 3,356 | — | $0 | 3,356 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2022-06-02 | 2022-06-06 | 15,750 | — | $0 | 15,750 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2022-06-02 | 2022-06-06 | 4,507 | — | $0 | 4,507 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2022-04-01 | 2022-04-04 | 99,000 | — | $0 | 99,000 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2022-01-24 | 2022-01-26 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | P Buy | 2021-11-24 | 2021-11-24 | 7,500 | $12.19 | $91.4K | 17,500 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2021-07-26 | 2021-07-28 | 66,667 | — | $0 | 66,667 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2021-07-08 | 2021-07-12 | 124,000 | — | $0 | 124,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2021-06-03 | 2021-06-04 | 3,356 | — | $0 | 3,356 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2021-06-03 | 2021-06-04 | 12,250 | — | $0 | 12,250 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | S Sale | 2021-01-12 | 2021-01-12 | 3,210 | $4.20 | $13.5K | 208,611 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2021-01-08 | 2021-01-12 | 95,000 | — | $0 | 95,000 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | S Sale | 2021-01-05 | 2021-01-11 | 2,740 | $3.91 | $10.7K | 211,821 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | S Sale | 2020-12-22 | 2020-12-22 | 37,169 | $4.32 | $160.6K | 214,561 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award | 2020-12-18 | 2020-12-22 | 128,170 | — | $0 | 251,730 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2020-07-21 | 2020-07-23 | 92,000 | — | $0 | 92,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2020-06-04 | 2020-06-08 | 16,500 | — | $0 | 16,500 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2020-01-10 | 2020-01-14 | 92,000 | — | $0 | 92,000 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award | 2020-01-10 | 2020-01-14 | 37,000 | — | $0 | 123,560 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2020-01-07 | 2020-01-09 | 22,000 | — | $0 | 22,000 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | S Sale | 2020-01-07 | 2020-01-10 | 3,006 | $1.78 | $5.4K | 86,560 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | S Sale | 2020-01-07 | 2020-01-14 | 3,006 | $1.78 | $5.4K | 86,560 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | D To issuer deriv | 2019-12-17 | 2019-12-17 | 4,000 | — | $0 | 0 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | D To issuer deriv | 2019-12-17 | 2019-12-17 | 4,000 | — | $0 | 0 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | D To issuer deriv | 2019-12-17 | 2019-12-17 | 6,000 | — | $0 | 0 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | D To issuer deriv | 2019-12-17 | 2019-12-17 | 37,203 | — | $0 | 0 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | U Tender | 2019-12-17 | 2019-12-17 | 3,000 | $114.50 | $343.5K | 0 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2019-07-09 | 2019-07-11 | 84,500 | — | $0 | 84,500 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | M Exercise deriv | 2019-05-30 | 2019-06-03 | 1,500 | — | $0 | 1,500 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | M Exercise | 2019-05-30 | 2019-06-03 | 1,500 | — | $0 | 3,000 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2019-01-03 | 2019-01-07 | 84,500 | — | $0 | 84,500 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award | 2019-01-03 | 2019-01-07 | 33,750 | — | $0 | 89,566 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | P Buy | 2018-12-24 | 2018-12-26 | 15,000 | $2.93 | $44.0K | 55,816 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2018-08-13 | 2018-08-15 | 65,000 | — | $0 | 65,000 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | P Buy | 2018-08-07 | 2018-08-08 | 10,000 | $5.51 | $55.1K | 40,816 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2018-06-13 | 2018-06-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award | 2018-06-13 | 2018-06-15 | 5,000 | — | $0 | 10,000 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | M Exercise deriv | 2018-05-31 | 2018-05-31 | 1,500 | — | $0 | 0 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | M Exercise | 2018-05-31 | 2018-05-31 | 1,500 | — | $0 | 1,500 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | A Award deriv | 2018-05-30 | 2018-05-31 | 4,000 | — | $0 | 4,000 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | A Award deriv | 2018-05-30 | 2018-05-31 | 1,500 | — | $0 | 1,500 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2018-01-03 | 2018-01-05 | 600,000 | $2.24 | $1.34M | 600,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2017-06-15 | 2017-06-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award | 2017-06-15 | 2017-06-19 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | A Award deriv | 2017-05-31 | 2017-06-02 | 4,000 | — | $0 | 4,000 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | A Award deriv | 2017-05-31 | 2017-06-02 | 1,500 | — | $0 | 1,500 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2017-01-03 | 2017-01-06 | 300,000 | — | $0 | 300,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2016-06-16 | 2016-06-17 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | A Award deriv | 2016-06-01 | 2016-06-03 | 6,000 | — | $0 | 6,000 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | P Buy | 2016-03-15 | 2016-03-17 | 40,000 | $1.97 | $78.8K | 246,527 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2016-01-06 | 2016-01-08 | 300,000 | — | $0 | 300,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2015-06-18 | 2015-06-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | P Buy | 2014-12-12 | 2014-12-15 | 200,000 | $4.00 | $800.0K | 200,000 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2014-12-01 | 2014-12-03 | 2,000,000 | — | $0 | 2,000,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2014-05-22 | 2014-05-27 | 15,000 | — | $0 | 15,000 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 80,521 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 80,521 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 17,500 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 33,714 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 54,932 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 65,299 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 71,447 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 61,420 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 54,530 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | A Award | 2014-01-24 | 2014-01-28 | 311,798 | — | $0 | 311,798 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer | 2014-01-24 | 2014-01-28 | 311,798 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | U Tender | 2014-01-24 | 2014-01-28 | 482,281 | $50.00 | $24.11M | 0 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2014-01-17 | 2014-01-21 | 3,778 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2014-01-17 | 2014-01-21 | 6,251 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2014-01-17 | 2014-01-21 | 6,561 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2014-01-17 | 2014-01-21 | 5,068 | — | $0 | 54,932 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2014-01-17 | 2014-01-21 | 7,407 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2014-01-17 | 2014-01-21 | 12,690 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2014-01-17 | 2014-01-21 | 11,286 | — | $0 | 33,714 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2014-01-17 | 2014-01-21 | 7,503 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2014-01-17 | 2014-01-21 | 18,582 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2014-01-17 | 2014-01-21 | 7,407 | $13.50 | $100.0K | 458,305 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2014-01-17 | 2014-01-21 | 3,778 | $9.99 | $37.7K | 450,898 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2014-01-17 | 2014-01-21 | 6,251 | $9.96 | $62.3K | 447,120 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2014-01-17 | 2014-01-21 | 6,561 | $15.24 | $100.0K | 440,869 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2014-01-17 | 2014-01-21 | 5,068 | $19.73 | $100.0K | 434,308 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2014-01-17 | 2014-01-21 | 7,503 | $7.05 | $52.9K | 429,240 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2014-01-17 | 2014-01-21 | 18,582 | $3.14 | $58.3K | 421,737 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2014-01-17 | 2014-01-21 | 11,286 | $8.86 | $100.0K | 482,281 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2014-01-17 | 2014-01-21 | 12,690 | $5.91 | $75.0K | 470,995 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2014-01-06 | 2014-01-07 | 40,309 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2014-01-06 | 2014-01-07 | 40,309 | $3.55 | $143.1K | 403,155 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2013-12-18 | 2013-12-20 | 111,222 | — | $0 | 3,778 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2013-12-18 | 2013-12-20 | 60,000 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2013-12-18 | 2013-12-20 | 48,439 | — | $0 | 6,561 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2013-12-18 | 2013-12-20 | 50,000 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2013-12-18 | 2013-12-20 | 18,749 | — | $0 | 6,251 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2013-12-18 | 2013-12-20 | 32,497 | — | $0 | 7,503 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2013-12-18 | 2013-12-20 | 76,593 | — | $0 | 7,407 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2013-12-18 | 2013-12-20 | 1,310 | — | $0 | 12,690 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2013-12-18 | 2013-12-20 | 135,000 | — | $0 | 45,000 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2013-12-18 | 2013-12-20 | 52,500 | — | $0 | 17,500 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2013-12-18 | 2013-12-20 | 135,000 | $8.86 | $1.20M | 416,541 | SEC↗ |
| VPHM VIROPHARMA INC | F Tax w/h | 2013-12-18 | 2013-12-20 | 522 | $49.74 | $26.0K | 281,541 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2013-12-18 | 2013-12-20 | 1,310 | $5.91 | $7.7K | 282,063 | SEC↗ |
| VPHM VIROPHARMA INC | F Tax w/h | 2013-12-18 | 2013-12-20 | 46,649 | $49.74 | $2.32M | 280,753 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2013-12-18 | 2013-12-20 | 76,593 | $13.50 | $1.03M | 327,402 | SEC↗ |
| VPHM VIROPHARMA INC | F Tax w/h | 2013-12-18 | 2013-12-20 | 63,528 | $49.74 | $3.16M | 250,809 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2013-12-18 | 2013-12-20 | 111,222 | $9.99 | $1.11M | 314,337 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2013-12-18 | 2013-12-20 | 18,749 | $9.96 | $186.7K | 213,819 | SEC↗ |
| VPHM VIROPHARMA INC | F Tax w/h | 2013-12-18 | 2013-12-20 | 30,706 | $49.74 | $1.53M | 195,070 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2013-12-18 | 2013-12-20 | 50,000 | $13.97 | $698.5K | 225,776 | SEC↗ |
| VPHM VIROPHARMA INC | F Tax w/h | 2013-12-18 | 2013-12-20 | 30,410 | $49.74 | $1.51M | 175,776 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2013-12-18 | 2013-12-20 | 48,439 | $15.24 | $738.2K | 206,186 | SEC↗ |
| VPHM VIROPHARMA INC | F Tax w/h | 2013-12-18 | 2013-12-20 | 33,441 | $49.74 | $1.66M | 157,747 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2013-12-18 | 2013-12-20 | 60,000 | $8.71 | $522.6K | 191,188 | SEC↗ |
| VPHM VIROPHARMA INC | F Tax w/h | 2013-12-18 | 2013-12-20 | 15,655 | $49.74 | $778.7K | 131,188 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2013-12-18 | 2013-12-20 | 32,497 | $7.05 | $229.1K | 146,843 | SEC↗ |
| VPHM VIROPHARMA INC | F Tax w/h | 2013-12-18 | 2013-12-20 | 75,462 | $49.74 | $3.75M | 341,079 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2013-12-18 | 2013-12-20 | 52,500 | $11.31 | $593.8K | 393,579 | SEC↗ |
| VPHM VIROPHARMA INC | F Tax w/h | 2013-12-18 | 2013-12-20 | 30,733 | $49.74 | $1.53M | 362,846 | SEC↗ |
| VPHM VIROPHARMA INC | F Tax w/h | 2013-12-18 | 2013-12-20 | 10,704 | $49.74 | $532.4K | 203,115 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2013-06-20 | 2013-06-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| VPHM VIROPHARMA INC | A Award deriv | 2013-06-10 | 2013-06-12 | 61,420 | — | $0 | 61,420 | SEC↗ |
| VPHM VIROPHARMA INC | A Award deriv | 2013-01-03 | 2013-01-07 | 65,299 | — | $0 | 65,299 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2012-11-28 | 2012-11-30 | 18,000 | — | $0 | 40,309 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2012-11-28 | 2012-11-30 | 18,000 | $3.55 | $63.9K | 112,416 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2012-11-08 | 2012-11-13 | 42,000 | — | $0 | 14,000 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2012-11-08 | 2012-11-13 | 41,418 | — | $0 | 18,582 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2012-11-08 | 2012-11-13 | 42,000 | $5.91 | $248.2K | 136,416 | SEC↗ |
| VPHM VIROPHARMA INC | S Sale | 2012-11-08 | 2012-11-13 | 41,418 | $24.54 | $1.02M | 94,416 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2012-11-08 | 2012-11-13 | 41,418 | $3.14 | $130.1K | 135,834 | SEC↗ |
| VPHM VIROPHARMA INC | S Sale | 2012-11-08 | 2012-11-13 | 42,000 | $24.54 | $1.03M | 94,416 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2012-06-14 | 2012-06-18 | 15,000 | — | $0 | 15,000 | SEC↗ |
| VPHM VIROPHARMA INC | A Award deriv | 2012-06-04 | 2012-06-06 | 71,447 | — | $0 | 71,447 | SEC↗ |
| VPHM VIROPHARMA INC | A Award deriv | 2012-01-05 | 2012-01-06 | 54,530 | — | $0 | 54,530 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2012-01-04 | 2012-01-06 | 2,795 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2012-01-04 | 2012-01-06 | 7,205 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | F Tax w/h | 2012-01-04 | 2012-01-06 | 7,224 | $27.91 | $201.6K | 94,384 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2012-01-04 | 2012-01-06 | 7,205 | $27.91 | $201.1K | 101,608 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2012-01-04 | 2012-01-06 | 2,795 | $27.91 | $78.0K | 94,403 | SEC↗ |